These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17826308)

  • 1. A single-institute phase I/II trial combining nedaplatin dose escalation with a fixed dose of docetaxel for induction chemotherapy of oral squamous cell carcinoma.
    Miyazaki A; Kobayashi J; Yamamoto T; Kido Y; Takemura K; Abe M; Tomihara K; Dehari H; Nakamori K; Nagai I; Hiratsuka H
    Oral Oncol; 2008 May; 44(5):471-6. PubMed ID: 17826308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter phase I trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.
    Kurita H; Yamamoto E; Nozaki S; Wada S; Furuta I; Kurashina K
    Oral Oncol; 2004 Nov; 40(10):1000-6. PubMed ID: 15509491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.
    Kurita H; Yamamoto E; Nozaki S; Wada S; Furuta I; Miyata M; Kurashina K
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):503-8. PubMed ID: 19579024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
    Sato Y; Takayama T; Sagawa T; Okamoto T; Miyanishi K; Sato T; Araki H; Iyama S; Abe S; Murase K; Takimoto R; Nagakura H; Hareyama M; Kato J; Niitsu Y
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):570-6. PubMed ID: 16463059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility study of docetaxel and nedaplatin for recurrent squamous cell carcinoma of the uterine cervix.
    Watanabe Y; Nakai H; Etoh T; Kanemura K; Tsuji I; Ishizu A; Hoshiai H
    Anticancer Res; 2008; 28(4C):2385-8. PubMed ID: 18751423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
    Kajiura S; Hosokawa A; Yoshita H; Ueda Y; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
    Am J Clin Oncol; 2016 Feb; 39(1):13-7. PubMed ID: 24322336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer.
    Kodaira T; Fuwa N; Tachibana H; Hidano S
    Anticancer Res; 2006; 26(3B):2265-8. PubMed ID: 16821599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
    Xu RH; Shi YX; Guan ZZ; Jiang WQ; Huang H; Ma ZY; Wang JH; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C
    Ai Zheng; 2006 Dec; 25(12):1565-8. PubMed ID: 17166388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase I study of the combination of nedaplatin (NED), adriamycin (ADM), and 5-fluorouracil (5-FU) (NAF) for treatment of unresectable advanced esophageal cancer].
    Hirao M; Fujitani K; Tsujinaka T
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):53-6. PubMed ID: 15675582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation.
    Yoshioka T; Sakayori M; Kato S; Chiba N; Miyazaki S; Nemoto K; Shibata H; Shimodaira H; Ohtsuka K; Kakudo Y; Sakata Y; Ishioka C
    Int J Clin Oncol; 2006 Dec; 11(6):454-60. PubMed ID: 17180514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck.
    Tsukuda M; Mikami Y; Tanigaki Y; Katori H; Horiuchi C; Ikeda Y; Taguchi T; Ono M; Yoshida T; Sakuma Y; Aikoh K
    Int J Clin Oncol; 2004 Jun; 9(3):161-6. PubMed ID: 15221599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma.
    Kodaira T; Fuwa N; Kamata M; Furutani K; Tachibana H; Yamazaki T
    Anticancer Res; 2006; 26(1B):471-8. PubMed ID: 16739307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel, nedaplatin, and S-1 (DGS) chemotherapy for advanced esophageal carcinoma: a phase I dose-escalation study.
    Tanaka Y; Yoshida K; Osada S; Yamaguchi K; Takahashi T
    Anticancer Res; 2011 Dec; 31(12):4589-97. PubMed ID: 22199335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 1/11 study of second-line chemotherapy with fractionated docetaxel and nedaplatin for 5-FU/cisplatin-resistant esophageal squamous cell carcinoma.
    Akutsu Y; Shuto K; Kono T; Uesato M; Hoshino I; Shiratori T; Miyazawa Y; Isozaki Y; Akanuma N; Matsubara H
    Hepatogastroenterology; 2012 Oct; 59(119):2095-8. PubMed ID: 22328303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer.
    Miyazaki T; Sohda M; Tanaka N; Suzuki S; Ieta K; Sakai M; Sano A; Yokobori T; Inose T; Nakajima M; Fukuchi M; Ojima H; Kato H; Kuwano H
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):853-7. PubMed ID: 23306309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer.
    Teramoto K; Asada Y; Ozaki Y; Suzumura Y; Nakano Y; Sawai S; Tezuka N; Inoue S; Fujino S
    Cancer Chemother Pharmacol; 2012 Oct; 70(4):531-7. PubMed ID: 22864949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase I/II clinical trial of induction chemotherapy with nedaplatin (CDGP), docetaxel (DOC) and 5-fluorouracil (5-FU) for squamous cell carcinoma of head and neck].
    Uchiyama K; Iwabuchi H; Nakayama S
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):43-8. PubMed ID: 17220668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ; Liu SP; Wang XE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.
    Huang CE; Lu CH; Chen PT; Chan CH; Chen WC; Wang WH; Wu JY; Kuan FC; Lee KD; Chen CC
    J Clin Pharm Ther; 2012 Jun; 37(3):342-7. PubMed ID: 21950487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase I study of a combination chemotherapy of nedaplatin and cisplatin].
    Nishida M; Satoh Y; Nishide K; Tsunoda H; Kubo T
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2209-15. PubMed ID: 10635306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.